UPDATE: Canaccord On Edward Price Target Raise Post-Earnings: Firm Sees Market Dominance In Transcatheter Aortic Valve Replacements & 'Large Future Opportunity' In Transcatheter Mitral & Tricuspid Therapies; Notes Waning Covid Effects On Procedure Volumes